# Eli Lilly and Company (LLY) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $65.18B |
| 2024 | $45.04B |
| 2023 | $34.12B |
| 2022 | $28.54B |
| 2021 | $28.32B |
| 2020 | $24.54B |
| 2019 | $22.32B |
| 2018 | $21.49B |
| 2017 | $19.97B |
| 2016 | $21.22B |
| 2015 | $19.96B |
| 2014 | $19.62B |
| 2013 | $23.11B |
| 2012 | $22.60B |
| 2011 | $24.29B |
| 2010 | $23.08B |
| 2009 | $21.84B |
| 2008 | $20.37B |
| 2007 | $18.63B |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $19.80B |
| 2025-09-30 | $17.60B |
| 2025-06-30 | $15.56B |
| 2025-03-31 | $12.73B |
| 2024-09-30 | $11.44B |
| 2024-06-30 | $11.30B |
| 2024-03-31 | $8.77B |
| 2023-09-30 | $9.50B |
| 2023-06-30 | $8.31B |
| 2023-03-31 | $6.96B |
| 2022-09-30 | $6.94B |
| 2022-06-30 | $6.49B |
| 2022-03-31 | $7.81B |
| 2021-09-30 | $6.77B |
| 2021-06-30 | $6.74B |
| 2021-03-31 | $6.81B |
| 2020-09-30 | $5.74B |
| 2020-06-30 | $5.50B |
| 2020-03-31 | $5.86B |
| 2019-09-30 | $5.48B |
| 2019-06-30 | $5.64B |
| 2019-03-31 | $5.09B |
| 2018-09-30 | $5.31B |
| 2018-06-30 | $5.58B |

Source: [MarketCapTrends](https://marketcaptrends.com/company/LLY/revenue)